相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan The PARADIGM-HF Trial
Peder Langeland Myhre et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Angiotensin Receptor Neprilysin Inhibitor for Functional Mitral Regurgitation PRIME Study
Duk-Hyun Kang et al.
CIRCULATION (2019)
Sacubitril/valsartan reduces serum uric acid concentration, an independent predictor of adverse outcomes in PARADIGM-HF
Ulrik M. Mogensen et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
The reverse remodeling response to sacubitril/valsartan therapy in heart failure with reduced ejection fraction
Pieter Martens et al.
CARDIOVASCULAR THERAPEUTICS (2018)
Medical Therapy for Heart Failure With Reduced Ejection Fraction
Stephen J. Greene et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Effect of neprilysin inhibition on renal function in patients with type 2 diabetes and chronic heart failure who are receiving target doses of inhibitors of the renin-angiotensin system: a secondary analysis of the PARADIGM-HF trial
Milton Packer et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure
Kevin Damman et al.
JACC-HEART FAILURE (2018)
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
Clyde W. Yancy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Gap between guidelines and clinical practice in heart failure with reduced ejection fraction: Results from TSOC-HFrEF registry
Hung-Yu Chang et al.
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2017)
Chang Gung Research Database: A multi-institutional database consisting of original medical records
Ming-Shao Tsai et al.
BIOMEDICAL JOURNAL (2017)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski et al.
EUROPEAN HEART JOURNAL (2016)
Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trial
Orly Vardeny et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Chronic Kidney Disease and Outcomes in Heart Failure With Preserved Versus Reduced Ejection Fraction The Cardiovascular Research Network PRESERVE Study
David H. Smith et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2013)
Potential impact of optimal implementation of evidence-based heart failure therapies on mortality
Gregg C. Fonarow et al.
AMERICAN HEART JOURNAL (2011)